Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Nephron Sc Inc
FDA Inspection
•Nephron Sc Inc•February 10, 2023

Nephron Sc Inc – FDA Inspection, Feb 10, 2023

Record Details

This FDA Inspection record concerns Nephron Sc Inc, with an inspection on February 10, 2023, covering drugs.

Company
Nephron Sc Inc
Inspection Date
February 10, 2023
Product Type
Drugs
People
  • Clifton L. Randell (FDA Associated Person)
  • Jamie L. Port
  • June P. Page (FDA Associated Person)
  • Mary-Jeanet Mcgarry (FDA Associated Person)
  • Melanie M. Walker
  • Song Y. Lavalais
  • Sonya M. Edmonds (FDA Associated Person)
View Company Profile

ID · 5c6a8c2a-0cd7-4f46-bc21-9f3d518ae97d

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number
1197994
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued

FDA Citations

15
  1. 21 CFR 211.100(b)SOPs not followed / documented
  2. 21 CFR 211.110(a)Control procedures to monitor and validate performance
  3. 21 CFR 211.113(b)Validation lacking for sterile drug products
  4. 21 CFR 211.170(a)(1)Retention time for reserve samples of actives
  5. 21 CFR 211.194(a)Complete test data included in records
  6. 21 CFR 211.22(d)Procedures not in writing, fully followed
  7. 21 CFR 211.25(a)Training--operations, GMPs, written procedures
  8. 21 CFR 211.42(c)Defined areas of adequate size for operations
  9. 21 CFR 211.42(c)(10)(iii)Air Supply
  10. 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System

Showing 10 of 15 citations.

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Nephron Sc Inc

12
DateClassificationOfficeProject area
August 22, 2025Not classifiedAtlanta District OfficeDrug Quality Assurance
September 25, 2024Not classifiedAtlanta District OfficeDrug Quality Assurance
February 9, 2024OAICenter for Drug Evaluation and ResearchDrug Quality Assurance
April 20, 2022OAICenter for Drug Evaluation and ResearchDrug Quality Assurance
June 7, 2019NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 12 other inspections on the company page
Other documents for Nephron Sc Inc
  • FDA Inspection 1274364 - 2025-08-22
  • FDA Inspection 1247772 - 2024-09-25
  • FDA Inspection 1229051 - 2024-02-09
  • FDA Inspection 1168119 - 2022-04-20
  • FDA Inspection 1099348 - 2019-06-07

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Nephron Sc Inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.